相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2015)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
Lucilla Parnetti et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
Yaroslau Compta et al.
PARKINSONISM & RELATED DISORDERS (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
Leslie M. Shaw et al.
ACTA NEUROPATHOLOGICA (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
M. A. Burack et al.
NEUROLOGY (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Normative symbol digit modalities test performance in a community-based sample
LK Sheridan et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
Brit Mollenhauer et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease
TA Hughes et al.
NEUROLOGY (2000)
分享论文
